This episode reviews two recent papers on the practice-changing BEe-HIVe study, which assessed efficacy of a relatively new hepatitis B vaccine (known as HepB-CpG, or trade name Heplisav-B) for persons with HIV, and the resulting clinical implications. View episode transcript and references at www.hiv.uw.edu. This podcast explores practice-changing issues and updates in HIV diagnosis, management, and prevention. The three podcast hosts include Lead Editor Dr. Brian Wood, Professor of Medicin...
All content for National HIV Curriculum Podcast is the property of National HIV Curriculum and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode reviews two recent papers on the practice-changing BEe-HIVe study, which assessed efficacy of a relatively new hepatitis B vaccine (known as HepB-CpG, or trade name Heplisav-B) for persons with HIV, and the resulting clinical implications. View episode transcript and references at www.hiv.uw.edu. This podcast explores practice-changing issues and updates in HIV diagnosis, management, and prevention. The three podcast hosts include Lead Editor Dr. Brian Wood, Professor of Medicin...
CROI 2025: Four More Potentially Practice-Changing Abstracts
National HIV Curriculum Podcast
24 minutes
6 months ago
CROI 2025: Four More Potentially Practice-Changing Abstracts
Dr. Jehan Budak and Dr. Raaka Kumbhakar, University of Washington Assistant Professors of Medicine, discuss CROI 2025 abstracts on the complexities of treating TB during pregnancy, the use of tenofovir alafenamide for people with TB, switching to the investigational ART combination doravirine/islatravir, and data on why people stop injectable cabotegravir/rilpivirine. View episode transcript and references at www.hiv.uw.edu. This podcast explores practice-changing issues and updates in HIV d...
National HIV Curriculum Podcast
This episode reviews two recent papers on the practice-changing BEe-HIVe study, which assessed efficacy of a relatively new hepatitis B vaccine (known as HepB-CpG, or trade name Heplisav-B) for persons with HIV, and the resulting clinical implications. View episode transcript and references at www.hiv.uw.edu. This podcast explores practice-changing issues and updates in HIV diagnosis, management, and prevention. The three podcast hosts include Lead Editor Dr. Brian Wood, Professor of Medicin...
